Table 1 Patient characteristics
From: Comparison of periodontal parameters between patients with ischemic and dilative cardiomyopathy
ICM (n = 113) | DCM (n = 113) | p value | |
|---|---|---|---|
Gender (female in % [n]) | 7.1% [8] | 7.1% [8] | 0.99 |
Age in years (mv ± sd) | 59.55 ± 7.61 [60.0, 55.0–65.0] | 59.54 ± 9.00 [61.0, 54.0–66.0] | 0.86 |
Smoking habits % [n] | |||
Smoker | 15.9% [18] | 15.9% [18] | 0.99 |
Non-smoker | 61.1% [69] | 61.1% [69] | |
Former smoker | 23% [26] | 23% [26] | |
Co-morbidities % [n] | |||
Hypertension | 73.5% [83] | 69.9% [79] | 0.66 |
Diabetes mellitus | 47.8% [54] | 41.6% [47] | 0.42 |
Renal insufficiency | 61.9% [70] | 62.8% [71] | 0.99 |
Osteoporosis | 1.8% [2] | 3.5% [4] | 0.68 |
Ejection fraction | 34.61 ± 16.80 [30.0, 23.0–53.0] | 32.84 ± 16.47 [26.9, 20.0–48.0] | 0.17 |
Disease/Therapy situation | |||
HTx | 29.2% [33] | 23.9% [27] | 0.50 |
LVAD | 46.0% [52] | 45.1% [51] | |
HF | 24.8% [28] | 31% [35] | |
Medication | |||
ACE-blocker | 84.7% [94/111] | 78.6% [88/112] | 0.30 |
Calcium channel clocker | 18.6% [21/111] | 14.3% [16/112] | 0.37 |
Anticoagulants | 64% [71/111] | 68.8% [77/112] | 0.48 |
Antiplatelet medication | 82.9% [92/111] | 75.9% [85/112] | 0.25 |
Immunosuppressive | 31.5% [35/111] | 26.8% [30/112] | 0.46 |
Insulin | 23.4% [26/111] | 17% [19/112] | 0.25 |
Oral antidiabetic drugs | 19.8% [22/111] | 17.9% [20/112] | 0.74 |
Bisphosphonates | 11.7% [13/111] | 14.3% [16/112] | 0.69 |
Laboratory values | |||
CRP (mg/dl) | 9.43 ± 18.94 [3.7, 1.7–7.8] | 13.40 ± 24.64 [3.8, 1.6–16.0] | 0.81 |
Creatinine (µmol/l) | 64.40 ± 112.41 [20.9, 1.2–96.6] | 51.81 ± 120.31 [20.4, 1.1–77.0] | 0.21 |
Haemoglobin (mmol/l) | 8.44 ± 1.69 [8.6, 7.8–9.1] | 7.84 ± 1.97 [8.0, 6.8–9.1] | 0.13 |
Erythrocytes (106/µl) | 4.51 ± 0.66 [4.5, 4.1–5.0] | 4.41 ± 0.82 [4.5, 3.8–5.0] | 0.61 |
Leukocytes (103/µl) | 7.57 ± 2.03 [7.9, 6.3–8.3] | 7.12 ± 2.73 [6.6, 5.2–8.3] | 0.13 |
Platelet count (103/µl) | 219.19 ± 79.20 [199.5, 169.0–268.0] | 231.82 ± 66.92 [225.5, 186.0–280.0] | 0.21 |